Mometason Spirig HC Nasenspray, Suspension
7680676410018
CH-67641
suspension
Associated product:
MOMETASONE Spirig HC 0.05 mg/dose fl 140 dos
1 / 2
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 140
- Selling units
- 140
- Measure
- Einzeldose(n)
- Galenic form
- suspension
- Galenic group
- unbekannt
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
mometasoni furoas
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
mometasoni furoas monohydricus
|
- | Substance | WIZUS |
|
benzalkonii chloridum
|
0.2 MG | Substance | HBESI |
|
glycerolum
|
- | Substance | HNIDK |
|
polysorbatum 80
|
- | Substance | HNIDK |
|
cellulosum microcristallinum et carmellosum natricum
|
- | Substance | HNIDK |
|
acidum citricum monohydricum
|
- | Substance | HNIDK |
|
natrii citras anhydricus
|
- | Substance | HNIDK |
|
aqua purificata
|
- | Substance | HNIDK |
|
mometasoni furoas
|
50.0 UG | Substance | Wirkstoff (Principe actif) |
Reimbursement information
Public price
CHF 16.05
Specialties list
Yes
Generic
Yes
SL addition date:
01/05/2016
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 67641
- Drug name
- Mometason Spirig HC Nasenspray, Suspension
- Galenic form
- NASSS
- ATC Code
- R01AD09
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 14/05/2020
- Authorization expiration date
- 31/12/9999
- IT Number
- 12.02.3.
- Domain
- Human medicine
Package details
- Description (FR)
- MOMETASONE Spirig HC 0.05 mg/dose fl 140 dos
- Description (DE)
- MOMETASON Spirig HC 0.05 mg/Dosis Fl 140 Dos
- Market launch
- 14/05/2020
- Narcotic (BTM)
- No
Original drug
Nasonex, Dosier-Nasenspray
GTIN: 7680541890365
CHF 18.15
Other package sizes (1)
MOMETASONE Spirig HC 0.05 mg/dose 3 fl 140 dos
3 x 140 EINZ
GTIN: 7680676410025